What symptoms do patients with multiple myeloma (Bence Jones disease) present with?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clinical Presentation of Multiple Myeloma (Bence Jones Disease)

Patients with multiple myeloma (Bence Jones disease) most commonly present with bone pain (particularly in the back, ribs, and pelvis), fatigue from anemia, and recurrent infections due to immunosuppression. 1

Cardinal CRAB Features

The classic presentation follows the CRAB criteria, which define symptomatic disease requiring treatment:

  • Hypercalcemia: Corrected serum calcium >11.5 mg/dL (>2.9 mmol/L), manifesting as constipation, confusion, polyuria, and weakness 1, 2
  • Renal insufficiency: Serum creatinine >2 mg/dL or creatinine clearance <40 mL/min, often caused by light chain cast nephropathy or hypercalcemia 1
  • Anemia: Hemoglobin <10 g/dL or >2 g/dL below normal, presenting as fatigue, weakness, and dyspnea—present in approximately 75% of patients at diagnosis 1
  • Bone lesions: Lytic lesions on skeletal imaging (present in 79-80% of patients), causing severe bone pain, pathological fractures, and vertebral collapse 1, 3

Skeletal Manifestations

Bone disease is the hallmark of multiple myeloma and the most frequent presenting symptom:

  • Severe bone pain, particularly in weight-bearing bones (vertebrae, ribs, pelvis, proximal femora and humeri) 1
  • Pathological fractures from osteolytic destruction without reactive bone formation 4, 3
  • Vertebral compression fractures leading to height loss and spinal cord compression 1
  • Hypercalcemia from excessive bone resorption 1, 2

Hematologic and Immunologic Features

Anemia is nearly universal and multifactorial:

  • Normochromic, normocytic anemia from bone marrow infiltration by plasma cells 1
  • Erythropoietin deficiency in patients with renal impairment 1
  • Direct apoptosis of erythroblasts induced by myeloma cells 1

Recurrent infections occur due to:

  • Immunoparesis (reduction in normal immunoglobulins) despite elevated monoclonal protein 5
  • Neutropenia from disease or treatment 1
  • Secondary immunodeficiency 5

Bence Jones Protein-Specific Features

In Bence Jones myeloma specifically (representing light chain-only disease):

  • Monoclonal free light chains detected in urine (median 0.49 g/24h) without intact immunoglobulin secretion 5
  • Paraproteinemia detectable in serum in 86% of cases by sensitive methods 5
  • Higher frequency of renal involvement due to light chain toxicity 1
  • Elevated serum free light chains (κ-FLC median 4358 mg/L, λ-FLC median 2225 mg/L) with abnormal κ/λ ratio 5

Additional Clinical Manifestations

  • Hyperviscosity syndrome: Rare, but can cause bleeding, visual disturbances, and neurologic symptoms 1
  • Peripheral neuropathy: From paraprotein deposition or treatment-related toxicity 1
  • Amyloidosis: In some cases with light chain deposition causing organ dysfunction 1
  • Thrombotic complications: Venous thromboembolism risk varies by treatment regimen (1-16%) 1

Critical Diagnostic Pitfall

CRAB features are not pathognomonic for multiple myeloma. Other malignancies, particularly diffuse large B-cell lymphoma, can present identically with hypercalcemia, renal dysfunction, anemia, and bone lesions 6. Always confirm diagnosis with bone marrow biopsy showing ≥10% clonal plasma cells and monoclonal protein detection by serum/urine protein electrophoresis, immunofixation, or serum free light chain assays 1, 7.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Criteria for Multiple Myeloma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Myeloma Bone Disease: A Comprehensive Review.

International journal of molecular sciences, 2021

Research

Bone markers in multiple myeloma.

European journal of cancer (Oxford, England : 1990), 2006

Research

Biochemical profile of Bence-Jones type multiple myeloma.

Klinicheskaia laboratornaia diagnostika, 2022

Guideline

Initial Treatment for Multiple Myeloma Meeting CRAB or SLiM Criteria

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.